Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
Study Overview
Brief Summary
To compare the activity of AZD8931 against placebo on the cell markers in cancer tumours
Detailed Description
A Randomised Double-Blind Placebo-controlled Multicentre Phase I Study to Assess the Biological Activity of AZD8931 in Patients with Early Breast Cancer who are Ineligible for Treatment with trastuzumab as defined by IHC status
Official Title
A Randomised Double-Blind Placebo-controlled Multicentre Phase I Study to Assess the Biological Activity of AZD8931 in Patients With Early Breast Cancer Who Are Ineligible for Treatment With Trastuzumab as Defined by IHC Status
Conditions
Breast Neoplasm
Intervention / Treatment
Drug: Drug-AZD8931
Drug: Drug-Placebo
Other Study ID Numbers
- D0102C00019